FDA Inspection
Tianjin Kingyork Pharmaceuticals Co., LtdTianjin Kingyork Pharmaceuticals Co., Ltd – FDA Inspection, Aug 27, 2019
Record Details
This FDA Inspection record concerns Tianjin Kingyork Pharmaceuticals Co., Ltd, with an inspection on August 27, 2019, issued by the Office of Inspections and Investigations, covering human drugs.
- Inspection Date
- August 27, 2019
- Product Type
- Human Drugs
View Company Profile
ID · 6bdf880c-9f37-427a-8c1a-04aa1d3a1c41
Inspection Facts
- Inspection number
- 1102217
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Tianjin Kingyork Pharmaceuticals Co., Ltd
6| Date | Classification | Office | Project area |
|---|---|---|---|
| July 31, 2026 | Not classified | Office of Inspections and Investigations | Drug Quality Assurance |
| July 26, 2024 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 31, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 29, 2018 | Not classified | Office of Inspections and Investigations | |
| September 1, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Tianjin Kingyork Pharmaceuticals Co., Ltd
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.